Page last updated: 2024-10-27

foscarnet and Nephrotic Syndrome

foscarnet has been researched along with Nephrotic Syndrome in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zanetta, G1
Maurice-Estepa, L1
Mousson, C1
Justrabo, E1
Daudon, M1
Rifle, G1
Tanter, Y1

Other Studies

1 other study available for foscarnet and Nephrotic Syndrome

ArticleYear
Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation.
    Transplantation, 1999, May-27, Volume: 67, Issue:10

    Topics: Acute Kidney Injury; AIDS-Associated Nephropathy; Antiviral Agents; Cytomegalovirus Infections; Fosc

1999